Abstract ID: 62 Dupilumab Efficacy and Safety up to 52 Weeks in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts B and C of the Randomized, Placebo-Controlled, Three-Part, Phase 3 LIBERTY EoE TREET Study | Publicación